Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Access your blood results via your GP, alternatively self perform blood tests can be delivered to your home from one of the companies below
It is provided for laboratory, analytical, and educational research purposes only
Development was discontinued because the Phase IIb trial of 536 subjects over 24 weeks failed to meet its primary efficacy endpoint
Small peptides enter the bloodstream within minutes of a subcutaneous injection, and compounds like BPC-157 and GHK-Cu act through gene-signaling cascades that work body-wide rather than only where the needle went
Elevated Dose: 4.8 mg total contains 3 mg GHK-Cu and 600 mcg each of BPC-157, TB-4, and KPV
His laboratory has published over 100 preclinical studies examining BPC-157s effects across multiple organ systems, contributing significantly to understanding peptide-based tissue repair mechanisms that inform multi-component formulations
